Not Yet RecruitingPhase 2ACTRN12609001015235
Nephro-protective effects of L-amino acids in critically ill patients. A phase II multicentre randomised controlled trial.
Nephro-protective effects of L-amino acids versus standard care/usual care in critically ill adult patients at risk of developing acute kidney injury. A phase II multi-centre randomised controlled trial.
Sponsor
National Health and Medical Research Council (NHMRC)
Enrollment
474 participants
Start Date
Jan 1, 2010
Study Type
Interventional
Conditions
Eligibility
Sex: Both males and femalesMin Age: 18 Yearss
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Supplementary infusion of L-amino acids to achieve 2g/kg/day total protein intake on each day for the entire duration of Intensive Care Unit (ICU) stay
Supplementary infusion of L-amino acids to achieve 2g/kg/day total protein intake on each day for the entire duration of Intensive Care Unit (ICU) stay
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12609001015235